Ann: H1 FY2020 Appendix 4D Preliminary Interim Report, page-41

Look at this interview

https://www.finnewsnetwork.com.au/archives/finance_news_network276591.html

and this thing about TGA's possible reclassification of CBD products.

What the company is hoping for is an early access scheme for CBD to be sold through PharmaCann. But it also hopes that the CBD products will be reclassified and available over the counter which allows it to use the e-commerce platform of HempFood to directly sell CBD products online. This is a saving. The silly expensive e-commerce implementation in the US and Europe was a waste of money.

Of course, this is "hope". If any of the two or both comes through this year, we will be a decent pop of share price. The Australian market is small though. So, it's all hype. The jump would be sold down like before.

The only thing that looks positive is the increase in online sales in Europe. The US market is really bad due to Covid-19. What I wonder is the hidden cards that the CEO claimed they had and not played yet. Their cash position is looking bad though. The cost is still too high.

Give me a pop of 4c and I am happy to get out.